Sales Target for Prasugrel Achievable Despite Add’l Indication Dropped: Daiichi Sankyo Pres. Nakayama

Daiichi Sankyo President Joji Nakayama Daiichi Sankyo President Joji Nakayama foresees that target sales for the antiplatelet agent prasugrel (overseas brand name: Effient/Efient) are achievable, even though the company gave up on its filing in the US and Europe for...read more